Jennifer M Hah, MD
Pain Management · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hah’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A100279 · Current
Licensed to practise in California · since 2007 · expires 2027-06-30 · Northeastern Ohio Universities College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$8,637
Medicare paid this office $8,637 for 58 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 11 | $1,901 | $146 |
| Return visit (30+ min) | 16 | $1,676 | $93 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $136 | $10 |
Who their Medicare patients are
58 Original Medicare patients in 2024. Average age 73 · Women 67% · Health risk score 1.61. Above the middle of the specialty; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 66% · Depression 38% · Cancer 33% · Coronary heart disease 29% · Chronic kidney disease 28% · Diabetes 21% · COPD 19%.
The office billed $264,382, Medicare allowed $10,996 and paid $8,637; for 102 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 58 | 102 | 73 | 1.61 | $264,382 | $8,637 |
| 2023 | 161 | 303 | 70 | 1.53 | $267,596 | $21,492 |
| 2022 | 201 | 313 | 67 | 1.77 | $170,659 | $18,957 |
| 2021 | 98 | 191 | 67 | 1.51 | $182,235 | $12,944 |
| 2020 | 88 | 179 | 66 | 1.65 | $98,671 | $11,370 |
| 2019 | 102 | 189 | 68 | 1.53 | $101,828 | $11,630 |
| 2018 | 185 | 379 | 68 | 1.78 | $191,092 | $25,409 |
| 2017 | 140 | 271 | 67 | 1.61 | $165,139 | $18,991 |
| 2016 | 178 | 290 | 65 | 1.54 | $162,283 | $21,900 |
| 2015 | 105 | 207 | 68 | 1.61 | $86,385 | $11,778 |
| 2014 | 135 | 263 | 67 | 1.37 | $120,298 | $16,527 |
| 2013 | 195 | 415 | 69 | 1.48 | $157,093 | $27,067 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 45 | $5,260 | $81 |
| New patient visit (60+ min) | 20 | $3,122 | $156 |
| Long return visit (40+ min) | 20 | $3,108 | $124 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 40 | $2,935 | $45 |
| Injection of trigger points, 1-2 muscles | 11 | $339 | $31 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 23 | $103 | $4 |
2022: 4 services
| New patient visit (60+ min) | 31 | $4,522 | $146 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 83 | $4,362 | $35 |
| Return visit (30+ min) | 26 | $3,084 | $81 |
| Injection of trigger points, 3 or more muscles | 14 | $524 | $37 |
2021: 5 services
| New patient visit (60+ min) | 14 | $2,139 | $153 |
| Return visit (30+ min) | 17 | $1,853 | $88 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 22 | $1,280 | $33 |
| Ultrasonic guidance for needle placement | 12 | $392 | $28 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $180 | $11 |
2020: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,782 | $68 |
| Return visit (30+ min) | 15 | $993 | $58 |
| Short return visit (20+ min) | 15 | $860 | $45 |
| Ultrasonic guidance for needle placement | 14 | $408 | $27 |
2019: 4 services
| New patient visit (60+ min) | 13 | $1,959 | $151 |
| Return visit (30+ min) | 13 | $1,349 | $64 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,137 | $33 |
| Ultrasonic guidance for needle placement | 19 | $505 | $27 |
2018: 9 services
| New patient visit (60+ min) | 26 | $3,874 | $149 |
| Return visit (30+ min) | 26 | $2,586 | $66 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 45 | $2,273 | $35 |
| Long return visit (40+ min) | 14 | $1,876 | $99 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,347 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,046 | $65 |
| Ultrasonic guidance for needle placement | 27 | $868 | $28 |
| Short return visit (20+ min) | 12 | $672 | $42 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 29 | $350 | $10 |
2017: 7 services
| New patient visit (60+ min) | 36 | $4,671 | $130 |
| New patient visit (45+ min) | 16 | $1,713 | $107 |
| Return visit (30+ min) | 21 | $1,684 | $70 |
| Ultrasonic guidance for needle placement | 34 | $958 | $27 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 13 | $648 | $46 |
| Injection of trigger points, 3 or more muscles | 14 | $471 | $34 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $337 | $11 |
2016: 7 services
| New patient visit (60+ min) | 45 | $6,252 | $139 |
| Return visit (30+ min) | 31 | $2,683 | $69 |
| New patient visit (45+ min) | 15 | $1,593 | $106 |
| Ultrasonic guidance for needle placement | 29 | $840 | $29 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 17 | $711 | $37 |
| Injection of trigger points, 3 or more muscles | 18 | $670 | $37 |
| Short return visit (20+ min) | 11 | $647 | $43 |
2015: 4 services
| Daily hospital management of continuous spinal drug administration | 33 | $3,014 | $57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 22 | $873 | $32 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 14 | $627 | $42 |
| Ultrasonic guidance for needle placement | 16 | $564 | $30 |
2014: 8 services
| New patient visit (60+ min) | 25 | $3,743 | $150 |
| Return visit (30+ min) | 25 | $1,682 | $58 |
| Long return visit (40+ min) | 11 | $1,086 | $99 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 27 | $1,059 | $38 |
| Ultrasonic guidance for needle placement | 27 | $839 | $30 |
| Short return visit (20+ min) | 14 | $638 | $38 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $625 | $35 |
| Fluoroscopic guidance for spine or back muscle injection | 11 | $328 | $27 |
2013: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 68 | $6,952 | $62 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 32 | $2,780 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,248 | $118 |
| New patient visit (60+ min) | 13 | $1,778 | $137 |
| Return visit (30+ min) | 21 | $1,483 | $67 |
| Daily hospital management of continuous spinal drug administration | 11 | $1,216 | $55 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 18 | $691 | $38 |
| Short return visit (20+ min) | 14 | $618 | $36 |
| Ultrasonic guidance for needle placement | 21 | $580 | $26 |
| Fluoroscopic guidance for spine or back muscle injection | 12 | $298 | $25 |
Money from drug and device companies
$1,141 in 2025
| 2025 | 5 | 8 | $400 | $1,141 |
| 2024 | 4 | 8 | None | $826 |
| 2023 | 4 | 19 | $8,060 | $10,564 |
| 2022 | 7 | 26 | $1,925 | $4,508 |
| 2021 | 6 | 14 | $7,300 | $10,369 |
| 2020 | 3 | 12 | $9,900 | $10,231 |
| 2019 | 5 | 12 | None | $1,694 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| SPR Therapeutics | Sprint Pns System | $400 | 1 payment
|
| Brixton Biosciences | Neural Ice | $268 | 3 payments
|
| Medtronic | Intellis Adaptivestim | $230 | 2 payments
|
| Biotronik Nro | Prospera | $172 | 1 payment
|
| Saluda Medical Americas | Evoke | $71 | 1 payment
|
See all 8 published payments
| Brixton Biosciences | Meals · 2025-11-16 | Neural Ice | $55 |
| Brixton Biosciences | Meals · 2025-11-14 | Neural Ice | $55 |
| Biotronik Nro | Meals · 2025-09-16 | Prospera | $172 |
| Medtronic | Meals · 2025-09-05 | Inceptiv | $64 |
| Medtronic | Meals · 2025-07-18 | Intellis Adaptivestim | $167 |
| Brixton Biosciences | Travel · 2025-05-08 | Neural Ice | $158 |
| Saluda Medical Americas | Meals · 2025-03-25 | Evoke | $71 |
| SPR Therapeutics | Consulting · 2025-01-02 | Sprint Pns System | $400 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $826
| Nalu Medical | Nalu Neurostimulation System | $420 | 4 payments
|
| Biotronik Nro | Prospera | $284 | 2 payments
|
| Abbott Laboratories | Eterna | $80 | 1 payment
|
| Curonix | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $41 | 1 payment
|
2023: $10,564
| Nalu Medical | Nalu Neurostimulation System | $9,654 | 10 payments
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $445 | 4 payments
|
| SPR Therapeutics | Sprint Pns System | $271 | 4 payments
|
| Saluda Medical Americas | Evoke Scs | $193 | 1 payment
|
2022: $4,508
| Nalu Medical | Nalu Neurostimulation System | $3,781 | 17 payments
|
| Painteq | Painteq | $338 | 1 payment
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W/Receiver | $137 | 4 payments
|
| Nevro | Omnia | $89 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $86 | 1 payment
|
| GRT US Holding | Qutenza | $43 | 1 payment
|
| Bioventus | Stimrouter Implantable Kit | $34 | 1 payment
|
2021: $10,369
| Nalu Medical | Nalu Neurostimulation System | $7,583 | 9 payments
|
| SPR Therapeutics | Sprint Pns System | $2,400 | 1 payment
|
| Vertos Medical | Mild Device Kit | $150 | 1 payment
|
| Foundation Fusion Solutions | None | $92 | 1 payment
|
| Abbott Laboratories | Proclaim Ipg | $82 | 1 payment
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W Receiver | $62 | 1 payment
|
2020: $10,231
| Nalu Medical | Nalu Neurostimulation System | $6,511 | 8 payments
|
| Lilly USA | None | $3,600 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $120 | 3 payments
|
2019: $1,694
| Bioness | Stimrouter for Pain | $708 | 1 payment
|
| Abbott Laboratories | Axium Ins Drg Ipg | $487 | 2 payments
|
| Nevro | Senza Spinal Cord Stimulation System | $248 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $162 | 2 payments
|
| Medtronic USA | Intellis | $89 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Nalu Medical, Inc. · Clinical Study of A Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (Comfort) · 2023 | Their institution | $52,845 |
| Nalu Medical, Inc. · Clinical Study of A Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (Comfort 2) · 2024 | Their institution | $6,066 |
| Nalu Medical, Inc. · Clinical Study of A Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (Comfort) · 2025 | Their institution | $2,602 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1366639445
- Licence
- CA A100279California A100279: Current · expires 2027-06-30
- Trained
- Northeastern Ohio University College of Medicine, 2005
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X); Federal specialty code 207L00000X (207L00000X); Federal specialty code 2083A0300X (2083A0300X)
- Mailing address
- 307a Emerson St, Palo Alto, CA, 94301
- NPI first listed
- 2007-10-02
- NPI last updated
- 2024-04-11
- NPI record certified
- 2024-04-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305